A new trading day began on Friday, with West Pharmaceutical Services, Inc. (NYSE: WST) stock price down -6.87% from the previous day of trading, before settling in for the closing price of $330.65. WST’s price has ranged from $265.00 to $413.70 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 11.96%. Meanwhile, its annual earnings per share averaged -18.31%. With a float of $72.00 million, this company’s outstanding shares have now reached $73.50 million.
The extent of productivity of a business whose workforce counts for 10600 workers is very important to gauge. In terms of profitability, gross margin is 34.92%, operating margin of 20.02%, and the pretax margin is 20.47%.
West Pharmaceutical Services, Inc. (WST) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Instruments & Supplies Industry. The insider ownership of West Pharmaceutical Services, Inc. is 0.59%, while institutional ownership is 96.13%. The most recent insider transaction that took place on Aug 19 ’24, was worth 308,700. In this transaction VP & Treasurer of this company sold 1,029 shares at a rate of $300.00, taking the stock ownership to the 1,478 shares. Before that another transaction happened on May 10 ’24, when Company’s Director sold 617 for $365.92, making the entire transaction worth $225,773. This insider now owns 43,565 shares in total.
West Pharmaceutical Services, Inc. (WST) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of 1.83 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.66 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -18.31% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 2.50% during the next five years compared to 23.49% growth over the previous five years of trading.
West Pharmaceutical Services, Inc. (NYSE: WST) Trading Performance Indicators
Here are West Pharmaceutical Services, Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.75. Likewise, its price to free cash flow for the trailing twelve months is 69.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 6.74, a number that is poised to hit 1.75 in the next quarter and is forecasted to reach 7.53 in one year’s time.
Technical Analysis of West Pharmaceutical Services, Inc. (WST)
The latest stats from [West Pharmaceutical Services, Inc., WST] show that its last 5-days average volume of 1.06 million was superior to 0.56 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 42.53%. Additionally, its Average True Range was 12.11.
During the past 100 days, West Pharmaceutical Services, Inc.’s (WST) raw stochastic average was set at 49.15%, which indicates a significant increase from 37.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 69.68% in the past 14 days, which was higher than the 44.66% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $300.25, while its 200-day Moving Average is $338.01. Now, the first resistance to watch is $323.81. This is followed by the second major resistance level at $339.70. The third major resistance level sits at $348.77. If the price goes on to break the first support level at $298.86, it is likely to go to the next support level at $289.79. The third support level lies at $273.90 if the price breaches the second support level.
West Pharmaceutical Services, Inc. (NYSE: WST) Key Stats
With a market capitalization of 22.30 billion, the company has a total of 72,843K Shares Outstanding. Currently, annual sales are 2,950 M while annual income is 593,400 K. The company’s previous quarter sales were 746,900 K while its latest quarter income was 136,000 K.
